{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "63833-892",
      "generic_name": "FIBRINOGEN HUMAN",
      "labeler_name": "CSL Behring GmbH",
      "brand_name": "Riastap",
      "active_ingredients": [
        {
          "name": "FIBRINOGEN HUMAN",
          "strength": "2600 mg/100mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "63833-892-51",
          "description": "1 VIAL, GLASS in 1 CARTON (63833-892-51)  / 100 mL in 1 VIAL, GLASS (63833-892-90)",
          "marketing_start_date": "20090116",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "703efe5b-eb9f-4690-abb8-e446feaa702f",
      "product_type": "PLASMA DERIVATIVE",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20090116",
      "product_id": "63833-892_703efe5b-eb9f-4690-abb8-e446feaa702f",
      "application_number": "BLA125317",
      "brand_name_base": "Riastap",
      "pharm_class": [
        "Blood Coagulation Factors [CS]",
        "Human Blood Coagulation Factor [EPC]",
        "Increased Coagulation Activity [PE]"
      ]
    }
  ]
}